MEI Pharma Inc (MEIP)
2.81
+0.01
(+0.36%)
USD |
NASDAQ |
Nov 21, 16:00
2.80
-0.01
(-0.36%)
Pre-Market: 09:28
MEI Pharma Net Income (Quarterly): -8.007M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.007M |
| June 30, 2024 | -18.41M |
| March 31, 2024 | -9.127M |
| December 31, 2023 | -11.06M |
| September 30, 2023 | 56.37M |
| June 30, 2023 | -10.03M |
| March 31, 2023 | -15.44M |
| December 31, 2022 | 10.25M |
| September 30, 2022 | -16.62M |
| June 30, 2022 | -16.06M |
| March 31, 2022 | -8.725M |
| December 31, 2021 | -12.16M |
| September 30, 2021 | -17.51M |
| June 30, 2021 | -8.378M |
| March 31, 2021 | -25.62M |
| December 31, 2020 | -8.026M |
| September 30, 2020 | 0.712M |
| June 30, 2020 | -19.63M |
| March 31, 2020 | -4.329M |
| December 31, 2019 | -20.22M |
| September 30, 2019 | -2.994M |
| June 30, 2019 | 3.053M |
| March 31, 2019 | -17.36M |
| December 31, 2018 | 12.02M |
| September 30, 2018 | -14.54M |
| Date | Value |
|---|---|
| June 30, 2018 | -19.25M |
| March 31, 2018 | -5.948M |
| December 31, 2017 | -6.079M |
| September 30, 2017 | -8.788M |
| June 30, 2017 | -4.343M |
| March 31, 2017 | -0.602M |
| December 31, 2016 | 11.88M |
| September 30, 2016 | -4.27M |
| June 30, 2016 | -5.77M |
| March 31, 2016 | -5.371M |
| December 31, 2015 | -5.101M |
| September 30, 2015 | -4.62M |
| June 30, 2015 | -5.662M |
| March 31, 2015 | -8.93M |
| December 31, 2014 | -9.109M |
| September 30, 2014 | -8.993M |
| June 30, 2014 | -8.541M |
| March 31, 2014 | -7.387M |
| December 31, 2013 | -6.324M |
| September 30, 2013 | -4.896M |
| June 30, 2013 | -3.215M |
| March 31, 2013 | -2.753M |
| December 31, 2012 | -2.754M |
| September 30, 2012 | -2.464M |
| June 30, 2012 | -2.101M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.62M
Minimum
Mar 2021
56.37M
Maximum
Sep 2023
-8.101M
Average
-10.55M
Median
Net Income (Quarterly) Benchmarks
| Avid Bioservices Inc | -5.534M |
| Evoke Pharma Inc | -1.312M |
| Revance Therapeutics Inc | -38.12M |
| NovaBay Pharmaceuticals Inc | -1.212M |
| Palatin Technologies Inc | -7.824M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.352M |
| EPS Diluted (Quarterly) | -1.20 |
| Enterprise Value | -8.182M |
| Earnings Yield | -248.8% |
| Operating Earnings Yield | 196.2% |
| Normalized Earnings Yield | 217.52 |